CorMedix Inc.(NasdaqGM:CRMD) dropped from Russell Small Cap Comp Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 USD | +0.86% | +11.55% | +56.65% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.65% | 324M | |
+13.12% | 9.23B | |
-13.75% | 5B | |
+41.51% | 4.46B | |
+4.51% | 3.95B | |
+21.10% | 2.44B | |
-15.23% | 2.54B | |
-25.12% | 2.36B | |
+19.51% | 2.18B | |
+5.11% | 1.67B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc.(NasdaqGM: CRMD) dropped from Russell Small Cap Comp Value Index